Drug Interactions with Herbal Medicines

In recent years, the issue of herbal medicine-drug interactions has generated significant concern. Such interactions can increase the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index (e.g. warfarin, ciclosporin and digoxin). The present article summariz...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacokinetics 2012-02, Vol.51 (2), p.77-104
Hauptverfasser: Shi, Shaojun, Klotz, Ulrich
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 104
container_issue 2
container_start_page 77
container_title Clinical pharmacokinetics
container_volume 51
creator Shi, Shaojun
Klotz, Ulrich
description In recent years, the issue of herbal medicine-drug interactions has generated significant concern. Such interactions can increase the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index (e.g. warfarin, ciclosporin and digoxin). The present article summarizes herbal medicine-drug interactions involving mainly inhibition or induction of cytochrome P450 enzymes and/or drug transporters. An increasing number of in vitro and animal studies, case reports and clinical trials evaluating such interactions have been reported, and the majority of the interactions may be difficult to predict. Potential pharmacodynamic and/or pharmacokinetic interactions of commonly used herbal medicines (black cohosh, garlic, Ginkgo , goldenseal, kava, milk thistle, Panax ginseng, Panax quinquefolius , saw palmetto and St John’s wort) with conventional drugs are presented, and sometimes the results are contradictory. Clinical implications of herbal medicine-drug interactions depend on a variety of factors, such as the co-administered drugs, the patient characteristics, the origin of the herbal medicines, the composition of their constituents and the applied dosage regimens. To optimize the use of herbal medicines, further controlled studies are urgently needed to explore their potential for interactions with conventional drugs and to delineate the underlying mechanisms.
doi_str_mv 10.2165/11597910-000000000-00000
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_916567775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2563563761</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-927c3314bd3004564f10f1d36ec1b3938765df82f3355d731a86a042540b46573</originalsourceid><addsrcrecordid>eNqFkE1PwzAMhiMEYmPwF1CFhDgV4nw2RzQ-NmmIC5yrNE1Gp60dSSvEvydT1-2IL7bkx_brF6EE8D0BwR8AuJIKcIqH6KsTNAaQKgVFxCkaYwok5UrQEboIYRWBjGB8jkaEEC6BqTG6e_LdMpnXrfXatFVTh-Snar-SmfWFXidvtqxMVdtwic6cXgd7tc8T9Pny_DGdpYv31_n0cZEaRqBNFZGGUmBFSTFmXDAH2EFJhTVQUEUzKXjpMuIo5byUFHQmNGaEM1wwwSWdoJt-79Y3350Nbb5qOl_Hk7mKnwspJY9Q1kPGNyF46_Ktrzba_-aA851B-WBQfjCor-Lo9X5_V2xseRgcHInA7R7Qwei187o2VThynFMi-E6D6rkQW_XS-qPQf0X8ATC1eh0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>916567775</pqid></control><display><type>article</type><title>Drug Interactions with Herbal Medicines</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Shi, Shaojun ; Klotz, Ulrich</creator><creatorcontrib>Shi, Shaojun ; Klotz, Ulrich</creatorcontrib><description>In recent years, the issue of herbal medicine-drug interactions has generated significant concern. Such interactions can increase the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index (e.g. warfarin, ciclosporin and digoxin). The present article summarizes herbal medicine-drug interactions involving mainly inhibition or induction of cytochrome P450 enzymes and/or drug transporters. An increasing number of in vitro and animal studies, case reports and clinical trials evaluating such interactions have been reported, and the majority of the interactions may be difficult to predict. Potential pharmacodynamic and/or pharmacokinetic interactions of commonly used herbal medicines (black cohosh, garlic, Ginkgo , goldenseal, kava, milk thistle, Panax ginseng, Panax quinquefolius , saw palmetto and St John’s wort) with conventional drugs are presented, and sometimes the results are contradictory. Clinical implications of herbal medicine-drug interactions depend on a variety of factors, such as the co-administered drugs, the patient characteristics, the origin of the herbal medicines, the composition of their constituents and the applied dosage regimens. To optimize the use of herbal medicines, further controlled studies are urgently needed to explore their potential for interactions with conventional drugs and to delineate the underlying mechanisms.</description><identifier>ISSN: 0312-5963</identifier><identifier>EISSN: 1179-1926</identifier><identifier>DOI: 10.2165/11597910-000000000-00000</identifier><identifier>PMID: 22257149</identifier><identifier>CODEN: CPKNDH</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Animals ; ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists &amp; inhibitors ; ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism ; Biological and medical sciences ; Cytochrome P-450 Enzyme Inhibitors ; Cytochrome P-450 Enzyme System - metabolism ; Enzyme Induction - drug effects ; General pharmacology ; Herb-Drug Interactions ; Humans ; Internal Medicine ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Pharmacotherapy ; Review Article</subject><ispartof>Clinical pharmacokinetics, 2012-02, Vol.51 (2), p.77-104</ispartof><rights>Adis Data Information BV 2012</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Wolters Kluwer Health Adis International Feb 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-927c3314bd3004564f10f1d36ec1b3938765df82f3355d731a86a042540b46573</citedby><cites>FETCH-LOGICAL-c421t-927c3314bd3004564f10f1d36ec1b3938765df82f3355d731a86a042540b46573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.2165/11597910-000000000-00000$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.2165/11597910-000000000-00000$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25532655$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22257149$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shi, Shaojun</creatorcontrib><creatorcontrib>Klotz, Ulrich</creatorcontrib><title>Drug Interactions with Herbal Medicines</title><title>Clinical pharmacokinetics</title><addtitle>Clin Pharmacokinet</addtitle><addtitle>Clin Pharmacokinet</addtitle><description>In recent years, the issue of herbal medicine-drug interactions has generated significant concern. Such interactions can increase the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index (e.g. warfarin, ciclosporin and digoxin). The present article summarizes herbal medicine-drug interactions involving mainly inhibition or induction of cytochrome P450 enzymes and/or drug transporters. An increasing number of in vitro and animal studies, case reports and clinical trials evaluating such interactions have been reported, and the majority of the interactions may be difficult to predict. Potential pharmacodynamic and/or pharmacokinetic interactions of commonly used herbal medicines (black cohosh, garlic, Ginkgo , goldenseal, kava, milk thistle, Panax ginseng, Panax quinquefolius , saw palmetto and St John’s wort) with conventional drugs are presented, and sometimes the results are contradictory. Clinical implications of herbal medicine-drug interactions depend on a variety of factors, such as the co-administered drugs, the patient characteristics, the origin of the herbal medicines, the composition of their constituents and the applied dosage regimens. To optimize the use of herbal medicines, further controlled studies are urgently needed to explore their potential for interactions with conventional drugs and to delineate the underlying mechanisms.</description><subject>Animals</subject><subject>ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists &amp; inhibitors</subject><subject>ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cytochrome P-450 Enzyme Inhibitors</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Enzyme Induction - drug effects</subject><subject>General pharmacology</subject><subject>Herb-Drug Interactions</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Review Article</subject><issn>0312-5963</issn><issn>1179-1926</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkE1PwzAMhiMEYmPwF1CFhDgV4nw2RzQ-NmmIC5yrNE1Gp60dSSvEvydT1-2IL7bkx_brF6EE8D0BwR8AuJIKcIqH6KsTNAaQKgVFxCkaYwok5UrQEboIYRWBjGB8jkaEEC6BqTG6e_LdMpnXrfXatFVTh-Snar-SmfWFXidvtqxMVdtwic6cXgd7tc8T9Pny_DGdpYv31_n0cZEaRqBNFZGGUmBFSTFmXDAH2EFJhTVQUEUzKXjpMuIo5byUFHQmNGaEM1wwwSWdoJt-79Y3350Nbb5qOl_Hk7mKnwspJY9Q1kPGNyF46_Ktrzba_-aA851B-WBQfjCor-Lo9X5_V2xseRgcHInA7R7Qwei187o2VThynFMi-E6D6rkQW_XS-qPQf0X8ATC1eh0</recordid><startdate>20120201</startdate><enddate>20120201</enddate><creator>Shi, Shaojun</creator><creator>Klotz, Ulrich</creator><general>Springer International Publishing</general><general>Adis International</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20120201</creationdate><title>Drug Interactions with Herbal Medicines</title><author>Shi, Shaojun ; Klotz, Ulrich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-927c3314bd3004564f10f1d36ec1b3938765df82f3355d731a86a042540b46573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists &amp; inhibitors</topic><topic>ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cytochrome P-450 Enzyme Inhibitors</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Enzyme Induction - drug effects</topic><topic>General pharmacology</topic><topic>Herb-Drug Interactions</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shi, Shaojun</creatorcontrib><creatorcontrib>Klotz, Ulrich</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical pharmacokinetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shi, Shaojun</au><au>Klotz, Ulrich</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug Interactions with Herbal Medicines</atitle><jtitle>Clinical pharmacokinetics</jtitle><stitle>Clin Pharmacokinet</stitle><addtitle>Clin Pharmacokinet</addtitle><date>2012-02-01</date><risdate>2012</risdate><volume>51</volume><issue>2</issue><spage>77</spage><epage>104</epage><pages>77-104</pages><issn>0312-5963</issn><eissn>1179-1926</eissn><coden>CPKNDH</coden><abstract>In recent years, the issue of herbal medicine-drug interactions has generated significant concern. Such interactions can increase the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index (e.g. warfarin, ciclosporin and digoxin). The present article summarizes herbal medicine-drug interactions involving mainly inhibition or induction of cytochrome P450 enzymes and/or drug transporters. An increasing number of in vitro and animal studies, case reports and clinical trials evaluating such interactions have been reported, and the majority of the interactions may be difficult to predict. Potential pharmacodynamic and/or pharmacokinetic interactions of commonly used herbal medicines (black cohosh, garlic, Ginkgo , goldenseal, kava, milk thistle, Panax ginseng, Panax quinquefolius , saw palmetto and St John’s wort) with conventional drugs are presented, and sometimes the results are contradictory. Clinical implications of herbal medicine-drug interactions depend on a variety of factors, such as the co-administered drugs, the patient characteristics, the origin of the herbal medicines, the composition of their constituents and the applied dosage regimens. To optimize the use of herbal medicines, further controlled studies are urgently needed to explore their potential for interactions with conventional drugs and to delineate the underlying mechanisms.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>22257149</pmid><doi>10.2165/11597910-000000000-00000</doi><tpages>28</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0312-5963
ispartof Clinical pharmacokinetics, 2012-02, Vol.51 (2), p.77-104
issn 0312-5963
1179-1926
language eng
recordid cdi_proquest_journals_916567775
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Animals
ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors
ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism
Biological and medical sciences
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Enzyme System - metabolism
Enzyme Induction - drug effects
General pharmacology
Herb-Drug Interactions
Humans
Internal Medicine
Medical sciences
Medicine
Medicine & Public Health
Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions
Pharmacology. Drug treatments
Pharmacology/Toxicology
Pharmacotherapy
Review Article
title Drug Interactions with Herbal Medicines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T09%3A27%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20Interactions%20with%20Herbal%20Medicines&rft.jtitle=Clinical%20pharmacokinetics&rft.au=Shi,%20Shaojun&rft.date=2012-02-01&rft.volume=51&rft.issue=2&rft.spage=77&rft.epage=104&rft.pages=77-104&rft.issn=0312-5963&rft.eissn=1179-1926&rft.coden=CPKNDH&rft_id=info:doi/10.2165/11597910-000000000-00000&rft_dat=%3Cproquest_cross%3E2563563761%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=916567775&rft_id=info:pmid/22257149&rfr_iscdi=true